Origami-inspired ingestible metamaterial enables long-lasting oral delivery of therapeutics

A team led by researchers including F. Javid, S. Babaee, and J. Quigley reports a new way to keep medicines working in the gut for much longer than conventional oral formulations. The work, published in Nature Communications (2026), describes an ingestible material that borrows design principles from origami—folding into a compact form for swallowing, then transforming into a more functional structure once it reaches the digestive environment.

The concept centers on a metamaterial: a deliberately engineered network whose overall behavior arises from the geometry of its repeating elements. Rather than relying only on chemical stabilization or coating thickness, the authors tune the structure so it can unfold and adapt in response to mechanical and environmental cues inside the gastrointestinal tract.

After ingestion, the device is designed to expand and maintain a form that resists rapid breakdown. This persistence is the key to prolonging drug exposure at the target location. By controlling how the structure deploys, researchers can influence how long therapeutics remain associated with the material before being released or made available for absorption.

A major technical challenge in oral delivery is the mismatch between where drugs are intended to act and how quickly the digestive system clears them. The proposed origami-inspired architecture addresses this by extending the residence time of the carrier without requiring external guidance. The metamaterial’s geometry helps create a controlled mechanical state that is less susceptible to immediate disintegration.

The team emphasizes that the approach is compatible with therapeutic payloads, using the structural platform to modulate delivery duration. In effect, the medicine becomes coupled to a “deployable” scaffold, shifting the formulation problem from passive dissolution to active, geometry-driven timing.

Beyond residence time, the study highlights the potential of mechanical design to manage how energy is absorbed and transferred within the device. Origami motifs allow predictable folding and unfolding paths, offering a route to reproducible performance across manufacturing batches.

This strategy suggests a broader direction for drug delivery: engineering functional materials that behave differently across time and space. If further validated in vivo for safety and consistency, origami metamaterial carriers could complement existing approaches such as polymer capsules and implantable systems.

While still early, the reported results underline a viral, attention-grabbing idea—medicine that “opens” after ingestion—grounded in metamaterial physics rather than simple packaging. The work points toward oral therapies that act for hours instead of minutes, potentially reshaping how chronic treatments are administered.